Ascelia Pharma AB Financial Overview
Ascelia Pharma AB's market cap is currently €36.93M. The company's EPS TTM is €-0.012252093; its P/E ratio is -3.81; Ascelia Pharma AB is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
